Prometheus Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Prometheus Biosciences, Inc.‘s stocks are currently a part of 128 hedge funds’ portfolios, which represents 38.29% of the total amount of its stocks outstanding. This makes up a total of 15.55M shares of Prometheus Biosciences, Inc.. Compared to the previous quarter, the number fell by -59.12% or -22.49M shares fewer. As for the holding position changes, 40.63% (52) of current hedge fund investors increased the number of shares held, 32.03% (41) of current holders sold a part of the shares held, and 10.94% (14) closed the holdings completely. 26 hedge funds are new holders of Prometheus Biosciences, Inc. stock in Q1 2023, it is 20.31% of total holders.
Hedge funds holding Prometheus Biosciences (Q1 2016 – Q1 2023)
| Q1 2016 | 63 |
|---|---|
| Q2 2016 | 67 |
| Q3 2016 | 70 |
| Q4 2016 | 71 |
| Q1 2017 | 69 |
| Q2 2017 | 101 |
| Q3 2017 | 119 |
| Q4 2017 | 147 |
| Q1 2018 | 1 |
| Q2 2018 | 0 |
| Q4 2020 | 0 |
| Q1 2021 | 41 |
| Q2 2021 | 49 |
| Q3 2021 | 51 |
| Q4 2021 | 74 |
| Q1 2022 | 101 |
| Q2 2022 | 111 |
| Q3 2022 | 140 |
| Q4 2022 | 219 |
| Q1 2023 | 128 |
Hedge funds changes in Prometheus Biosciences positions (Q1 2016 – Q1 2023)
| Q1 2016 | 11 | 26 | 17 | 11 | -2 |
|---|---|---|---|---|---|
| Q2 2016 | 13 | 35 | 8 | 8 | 3 |
| Q3 2016 | 12 | 27 | 17 | 8 | 6 |
| Q4 2016 | 12 | 29 | 17 | 10 | 3 |
| Q1 2017 | 16 | 25 | 19 | 13 | -4 |
| Q2 2017 | 42 | 38 | 17 | 10 | -6 |
| Q3 2017 | 34 | 50 | 19 | 14 | 2 |
| Q4 2017 | 63 | 53 | 26 | 35 | -30 |
| Q1 2018 | 0 | 0 | 0 | 145 | -144 |
| Q2 2018 | 0 | 0 | 0 | 1 | -1 |
| Q4 2020 | 0 | 0 | 0 | 1 | -1 |
| Q1 2021 | 41 | 0 | 0 | 0 | 0 |
| Q2 2021 | 22 | 9 | 10 | 14 | -6 |
| Q3 2021 | 6 | 19 | 13 | 4 | 9 |
| Q4 2021 | 27 | 34 | 5 | 4 | 4 |
| Q1 2022 | 32 | 27 | 30 | 5 | 7 |
| Q2 2022 | 29 | 35 | 34 | 16 | -3 |
| Q3 2022 | 46 | 51 | 27 | 18 | -2 |
| Q4 2022 | 95 | 72 | 46 | 16 | -10 |
| Q1 2023 | 26 | 52 | 41 | 14 | -5 |
Hedge funds changes in Prometheus Biosciences stock options (Q1 2016 – Q1 2023)
| Q1 2016 | 0 | 0 |
|---|---|---|
| Q2 2016 | 0 | 9,000 |
| Q3 2016 | 0 | 5,000 |
| Q4 2016 | 0 | 4,000 |
| Q1 2017 | 136,000 | 0 |
| Q2 2017 | 179,000 | 0 |
| Q3 2017 | 470,000 | 0 |
| Q4 2017 | 4,851,000 | 3,884,000 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 7,377,000 | 67,000 |
| Q1 2022 | 5,376,000 | 0 |
| Q2 2022 | 1,362,000 | 13,937,000 |
| Q3 2022 | 38,715,000 | 41,391,000 |
| Q4 2022 | 220,029,000 | 230,194,000 |
| Q1 2023 | 31,149,394,000 | 4,358,244,000 |